Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

iShares Russell 2000 ETF

Palantir Technologies

PayPal

Roku

Direxion Daily Small Cap Bull 3x Shares

Upstart Holdings

Wall Street has punished these companies and funds excessively this year, so we are sharing these undervalued stocks to catch near 2020 lows. The post 7 Undervalued Stocks to Buy Before Investors Catch On appeared first on InvestorPlace.

7 Undervalued Stocks to Buy Before Investors Catch On

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays High Yield Bond & Syndicated Loan Conference on Wednesday, May 25, 2022, beginning at 10:30 a.m. Eastern time (9:30 a.m. Central time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE

Tenet to Participate in the Barclays High Yield Bond & Syndicated Loan Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2022 Healthcare Conference in Las Vegas, NV, on Tuesday, May 10, 2022, beginning at 1:40 p.m. Eastern time (10:40 a.m. Pacific time). A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYS

Tenet to Participate in BofA Securities 2022 Healthcare Conference

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) experienced a cybersecurity incident last week. The Company immediately suspended user access to impacted information technology applications, executed extensive cybersecurity protection protocols, and quickly took steps to restrict further unauthorized activity. Efforts to restore impacted information technology operations continue to make important progress. While there was temporary disruption to a subset of acute care operati

Tenet Reports Cybersecurity Incident

RBC Capital Markets views Tenet Healthcare Corp's (NYSE: THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds.  The analysts have raised the price target from $89 to $104 (41% upside) with.

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.

Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y

Tenet Healthcare Corporation (NYSE:THC ) Q1 2022 Earnings Conference Call April 21, 2022 10:00 AM ET Company Participants Will McDowell - IR Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Conference Call Participants Josh Raskin - Nephron Research Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Jason Cassorla - Citi Whit Mayo - SVB Leerink John Ransom - Raymond James Brian Tanquilut - Jefferies Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets Sarah James - Barclays Andrew Mok - UBS Operator Greetings and welcome to Tenet Healthcare Corporation First Quarter 2022 Earnings Conference Call.

Tenet Healthcare Corporation (THC) CEO Saum Sutaria on Q1 2022 Results - Earnings Call Transcript

Tenet (THC) delivered earnings and revenue surprises of 85.58% and 1.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Tops Q1 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2022 (Q1'22). Tenet's results for Q1'22 versus the quarter ended March 31, 2021 (Q1'21) follow: ($ in millions, except per share results) Q1'22 Q1'21 Net income available to Tenet common shareholders from continuing operations $139 $97 Net income available to Tenet common shareholders from continuing operations per diluted share $1.27 $0.90 Adjusted EBITDA exclud

Tenet Reports First Quarter 2022 Results; Retired over $800 Million of Debt to Date in 2022; Maintains 2022 Adjusted EBITDA Outlook

Tenet Healthcare's (THC) first-quarter 2022 results are likely to reflect an improvement in adjusted admissions and outpatient admissions.

Can Tenet Healthcare (THC) Post Q1 Earnings Beat on Low Costs?

Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Tenet Healthcare (THC) This Earnings Season?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its first quarter ending March 31, 2022, after the market closes on Wednesday, April 20, 2022. The company will host a related conference call the following morning, Thursday, April 21, 2022, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About T

Tenet to Report its First Quarter 2022 Results on April 20

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Will McDowell as Vice President, Investor Relations. McDowell will join Tenet on March 31, 2022, after more than two decades serving in leadership roles at Cigna Corporation. McDowell currently serves as Cigna's Vice President, Strategy and Corporate Development, where he is responsible for expanding relationships with private market buyers and implementing the company's mergers and acquisitions

Tenet Appoints Will McDowell to Lead Investor Relations

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it has entered into an amendment to its existing senior secured revolving credit facility. The amendment has an effective date of March 16, 2022 and amends certain provisions under the credit agreement to, among other things, (i) provide for aggregate revolving commitments not to exceed $1.5 billion, subject to borrowing availability, (ii) extend the maturity date to March 16, 2027 and (iii) replace LIBOR wit

Tenet Announces Amendment to its Credit Agreement

Growing revenues, strong performances exhibited by segments, numerous acquisitions and sturdy financial standing continue to drive Tenet Healthcare (THC).

Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?

Let's see if Tenet Healthcare Corporation (THC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Should Value Investors Pick Tenet Healthcare (THC) Stock Now?

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Tenet (THC) Up 16.7% Since Last Earnings Report: Can It Continue?

HCA Healthcare

MEDNAX

Universal Health Services

Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.

4 Stocks to Watch From the Flourishing Hospital Industry

Hospital Stocks Hovering Near 52-Week Highs Despite Market Volatility

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the following investor conferences during March 2022: Raymond James & Associates' Institutional Investors Conference on Tuesday, March 8, 2022, beginning at 8:40 a.m. Eastern time (7:40 a.m. Central time). Barclays Global Healthcare Conference on Tuesday, March 15, 2022, beginning at 10:45 a.m. Eastern time (9:45 a.m. Central time). A live webcast and audio archive of each event may be accessed thro

Tenet to Participate in March 2022 Investor Conferences

Tenet Healthcare (THC) aborts its Conifer spin-off plan based on its solid business opportunities and strong pipeline prospects. It also reaffirmed its 2022 guidance.

Tenet Healthcare (THC) Drops Plans to Spin Off Conifer Segment

Shares of Tenet Healthcare Corp. THC, +0.33% were indicated down more than 1% in Tuesday's premarket, after the health care services company said it will no longer pursue a spinoff of its Conifer Health Solutions patient payments subsidiary. The company said it made its decision to have Conifer remain part of Tenet after a review by the company's board of directors and financial and legal advisors, and include expectations that Conifer can deliver fiscal 2022 revenue growth in the mid- to high-single-digit percentage range and have a "strong" margin and cash flow profile.

Tenet Healthcare abandons plan to spin off Conifer Health subsidiary

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) announced today that – based on ongoing shareholder value creation opportunities and improved business fundamentals – the Company will no longer pursue a spinoff of its Conifer Health Solutions subsidiary. The decision for Conifer to remain part of Tenet was made following a thorough review by Tenet's Board of Directors in consultation with independent legal and financial advisors and in consideration of the best interests of Ten

Conifer to Remain Part of Tenet with Strong Path Forward

Tenet Healthcare Corp (NYSE:THC)  stock is up 7.8% to trade at $79.88 this morning, following a round of post-earnings upgrades.

Analysts Blast Tenet Healthcare Stock After Monday's Earnings Beat

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) yesterday called for the redemption of all of the $700 million aggregate principal amount outstanding of its 7.500% senior secured first lien notes due April 1, 2025 (the “Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001, by and between Tenet and The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, as supplemented by the Thirty-Fourth Supplemental Indentu

News for Tenet Healthcare Stock (THC)